When stimulated by processed tumor antigen-derived peptides, naïve CD8+ T cells differentiate into effector CD8 + T cells and are further activated into cytotoxic CD8+ T cells and memory CD8 + T cells to exert their targeting effects at the tumor site [144]. The gene discussed is CD8A; the disease is neoplasm.